SecBot SecBot

VCTR

Victory Capital Holdings, Inc.
Nasdaq· Investment Advice· Inc. DE· CIK 0001570827 Traditional Finance
$108.91 +1.31 (+1.22%)
Oct 26 4:00 PM ET · prev $107.60
Market cap
$6.6B
Mid cap
Consensus
Buy
54% Buy or better · 13 analysts
Median target
$119.00
+9% · range $115.00–146.00
Next earnings
Nov 4
in 9 days
1 year
+69.1%
from $64.41 · Oct 27
30 days
−0.6%
from $109.60
52-week range
$60.76–121.13
−10% from high · low Dec 2
Avg volume 20D
579.9K
shares / day
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · since Mar 15
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
15
analyzed by SecBot
SecBot read MIXED 6 reports · 90 days
Balance 0 bearish · 1 bullish · 1 mixed · 4 neutral oldest → newest, height = score
Avg score ·High conf. 5/6 ·Next Earnings date, Nov 4, 2026
Strongest NEUTRAL Victory Capital Holdings is seeking stockholder approval to issue shares representing up to 17.4% of its…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since Mar 15. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 21 added (0 new), 19 trimmed or exited.

  • AnalystsBULLISH

    7 of 13 rate it Buy or better. Every target is above the price.

  • TrendRANGE

    2% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
AMERICAN CENTURY COMPANIES INCDOUBLED1,001,129$84.2M
GOLDMAN SACHS GROUP INCADD686,893$57.7M
MORGAN STANLEYADD458,978$38.6M
FIL LtdTRIM393,900$33.1M
AMERIPRISE FINANCIAL INCDOUBLED375,703$31.6M
PUBLIC SECTOR PENSION INVESTMENT BOARDADD309,891$26.0M
Swedbank ABTRIM250,000$21.0M
FIRST TRUST ADVISORS LPADD136,325$11.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

13 analysts
Buy 54% rate it Buy or better
Strong Buy3Buy4Hold6Sell0Strong Sell0
12-month targets · 6 analysts

Price is below the lowest target. Median implies +9%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Oct 16, 2026JP Morgan
MAINTAIN
MAINTAINNeutral
Oct 14, 2026Barclays
MAINTAIN
MAINTAINEqual-Weight
Sep 25, 2026Morgan Stanley
MAINTAIN
MAINTAINEqual-Weight
Aug 28, 2026Goldman Sachs
MAINTAIN
MAINTAINNeutral
Aug 7, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Aug 7, 2026Barclays
MAINTAIN
MAINTAINEqual-Weight

Insider ledger

Form 4
$0
open-market buys or sells · since Mar 15
DateInsiderTypeValue
Oct 12, 2026
Crestview Partners II GP, L.P.
Director
AWARD$28.7K
Oct 12, 2026
Hirtler-Garvey Karin
Director
AWARD$28.7K
Oct 12, 2026
Rappaport Alan
Director
AWARD$66.2K
Oct 12, 2026
Davanzo Lawrence
Director
AWARD$28.7K
Oct 12, 2026
Jackson Mary M.
Director
AWARD$28.7K
Oct 12, 2026
DEMARTINI RICHARD M
Director
AWARD$36.2K
Aug 13, 2026
Policarpo Michael Dennis
President, CFO & CAO
TAX W/H$4.0M
Aug 13, 2026
Policarpo Michael Dennis
President, CFO & CAO
EXERCISE73,763 sh

Earnings setup

Estimates
Nov 4
reports in 9 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q$2.02$1.95–$2.06-0.1%$417.6M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 16, 2026 SEC
Victory Capital Holdings is seeking stockholder approval to issue shares representing up to 17.4% of its capital stock…
DEFM14A — Impact 6/10
Oct 13, 2026 SEC
Victory Capital reported preliminary Q3 2026 AUM metrics, showing total client assets of $355.5 billion as of…
8-K — Impact 4/10
Oct 12, 2026 Insider
Crestview Partners II GP, L.P. was granted 259 shares
Director @ $110.95 ($28.7K)
Oct 12, 2026 Insider
Hirtler-Garvey Karin was granted 259 shares
Director @ $110.95 ($28.7K)
Oct 12, 2026 Insider
Rappaport Alan was granted 597 shares
Director @ $110.95 ($66.2K)
Sep 30, 2026 Short interest report
Short Interest: VCTR up 40% to 3.1M shares
Settlement 2026-09-30 | Days to cover: 4.24 | ≈5.08% of shares outstanding (est.)
Aug 31, 2026 SEC
Victory Capital (VCTR) has entered into a definitive agreement to acquire First Eagle (GC Ferry Holdings) from Genstar…
DEFA14A — Impact 7/10
Aug 19, 2026 Event
Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, Ascorbic Acid 20 mg, Benzyl Alcohol 1.5%, Na Hydroxide (Ph Adjust) in sterile water for injection, VMC.
Class I: Microbial Contamination of Sterile Products - out of specifications results were obtained f
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 4, 2026
Earnings date
VCTR Q3 2026 Earnings After Market Close — 2026-11-04
Recent
Sep 30, 2026
Short interest
Short Interest: VCTR up 40% to 3.1M shares
Settlement 2026-09-30 | Days to cover: 4.24 | ≈5.08% of shares outstanding (est.)
Sep 2, 2026
Press release
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Victory Capital Holdings, Inc. (NASDAQ: VCTR)
NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has…
Aug 19, 2026
FDA
Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, Ascorbic Acid 20 mg, Benzyl Alcohol 1.5%, Na Hydroxide (Ph Adjust) in sterile water for injection, VMC.
Class I: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Aug 19, 2026
FDA
Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, Ascorbic Acid 20 mg, Benzyl Alcohol 1.5%, Na Hydroxide (Ph Adjust) in sterile water for injection, VMC.
Class I: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Aug 19, 2026
FDA
Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, Ascorbic Acid 20 mg, Benzyl Alcohol 1.5%, Na Hydroxide (Ph Adjust) in sterile water for injection, VMC.
Class I: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

SecBot reports

15 filings · 3 bullish · 1 bearish · 1 mixed · 10 neutral
All VCTR filing & press-release reports (15)